The United States Food and Drug Administration’s staff endorsed the Johnson & Johnson single shot coronavirus vaccine for emergency use authorization on Wednesday following a detailed analysis of the jab.
The FDA’s vaccine advisers are set to meet on Friday to discuss recommending the vaccine for emergency use authorization, after which it is expected the agency will give it the green light promptly.
The vaccine developed by J&J was found to be 72% effective in US clinical trials and 85% effective in preventing severe disease across all regions where it was tested. The vaccine would be the third to be approved for use in the US, following the FDA’s approval of the Pfizer/BioNTech and Moderna jabs.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
